Literature DB >> 23135505

Clinical trials must cope better with multiplicity.

Janet Wittes1.   

Abstract

Clinical trials typically address more than one question. But in attempting to protect against misleading results that are due to chance when multiple interrelated tests are run simultaneously, researchers sometimes apply overly strict statistical devices that mask true effects. They should give more consideration to choosing the type of statistical analysis that fits best.

Entities:  

Mesh:

Year:  2012        PMID: 23135505     DOI: 10.1038/nm1112-1607

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  1 in total

Review 1.  Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.

Authors:  Evangelos C Rizos; Evangelia E Ntzani; Eftychia Bika; Michael S Kostapanos; Moses S Elisaf
Journal:  JAMA       Date:  2012-09-12       Impact factor: 56.272

  1 in total
  1 in total

1.  A wild bootstrap approach for the selection of biomarkers in early diagnostic trials.

Authors:  Antonia Zapf; Edgar Brunner; Frank Konietschke
Journal:  BMC Med Res Methodol       Date:  2015-05-01       Impact factor: 4.615

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.